The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Carbapenemases: Molecular Diversity and Clinical Consequences
Abstract
Carbapenemases are beta-lactamases that hydrolyze most beta-lactams including carbapenems. Carbapenemases are classified in four molecular classes; those belonging to class A are the chromosomally-encoded and clavulanic acid-inhibited IMI, NMC-A and SME, identified in Enterobacter cloacae and Serratia marcescens; the plasmid-encoded KPC enzymes identified in Enterobacteriaceae (and rarely in Pseudomonas aeruginosa); and the GES-type enzymes identified in Enterobacteriaceae and P. aeruginosa. The class B enzymes are the most clinically-significant carbapenemases; they are metallo-beta-lactamases, mostly of the IMP and the VIM series. They have been reported worldwide and their genes are plasmid- and integron-located, hydrolyzing all beta-lactams with the exception of aztreonam. One single plasmid-mediated AmpC beta-lactamase, CMY-10, identified in an Enterobacter aerogenes isolate, has been shown to be a cephaslosporinase with some carbapenemase properties. Finally, the class D carbapenemases are being increasingly reported, mostly in Acinetobacter baumannii, and they compromise the efficacy of imipenem and meropenem significantly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639 · cited 1×
“KPC-1 has been reported from a Klebsiella pneumoniae isolate from the USA that was resistant to carbapenems, extended-spectrum cephalosporins and aztreonam [20].”
BackgroundMetallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Self-citationCarbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology
Poirel, L., & Nordmann, P. (2006) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2006.01456.x · Cited by 1,051
Self-citationEmergence of Oxacillinase-Mediated Resistance to Imipenem in Klebsiella pneumoniae
Poirel, L., Héritier, C., Tolün, V., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.15-22.2004 · Cited by 997
Self-citationStokes, H. W., & Hall, R. M. (1989) · Molecular Microbiology · doi:10.1111/j.1365-2958.1989.tb00153.x · Cited by 885
Emerging carbapenemases in Gram-negative aerobes
Nordmann, P., & Poirel, L. (2002) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2002.00401.x · Cited by 684
Self-citationLauretti, L., Riccio, M. L., Mazzariol, A., Cornaglia, G., Amicosante, G., Fontana, R., & Rossolini, G. M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1584 · Cited by 677
IS CR Elements: Novel Gene-Capturing Systems of the 21st Century?
Toleman, M. A., Bennett, P. M., & Walsh, T. R. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00048-05 · Cited by 587
Bratu, S., Landman, D., Haag, R., Recco, R., Eramo, A., Alam, M., & Quale, J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1430 · Cited by 573
Poirel, L., Naas, T., Nicolas, D., Collet, L., Bellais, S., Cavallo, J.-D., & Nordmann, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.891-897.2000 · Cited by 562
Self-citationWoodford, N., Tierno, P. M., Young, K., Tysall, L., Palepou, M.-F. I., Ward, E., Painter, R. E., Suber, D. F., Shungu, D., Silver, L. L., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4793-4799.2004 · Cited by 442
Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H., Yoshimura, F., & Kato, N. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.71 · Cited by 440
Poirel, L., Le Thomas, I., Naas, T., Karim, A., & Nordmann, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.622-632.2000 · Cited by 421
Self-citationCarbapenem-hydrolyzing beta-lactamases
Rasmussen, B. A., & Bush, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.223 · Cited by 361
Lee, K., Yum, J. H., Yong, D., Lee, H. M., Kim, H. D., Docquier, J.-D., Rossolini, G. M., & Chong, Y. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.11.4485-4491.2005 · Cited by 333
Toleman, M. A. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf210 · Cited by 327
Villegas, M. V., Lolans, K., Correa, A., Kattan, J. N., Lopez, J. A., & Quinn, J. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01405-06 · Cited by 293
Afzal-Shah, M., Woodford, N., & Livermore, D. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.583-588.2001 · Cited by 282
Senda, K., Arakawa, Y., Nakashima, K., Ito, H., Ichiyama, S., Shimokata, K., Kato, N., & Ohta, M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.349 · Cited by 275
Héritier, C., Poirel, L., Lambert, T., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3198-3202.2005 · Cited by 272
Self-citationCastanheira, M., Toleman, M. A., Jones, R. N., Schmidt, F. J., & Walsh, T. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4654-4661.2004 · Cited by 261
Bou, G., Oliver, A., & Martínez-Beltrán, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1556-1561.2000 · Cited by 247
Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates
Smith Moland, E. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg124 · Cited by 245
Gales, A. C. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg416 · Cited by 242
Donald, H. M., Scaife, W., Amyes, S. G. B., & Young, H.-K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.1.196-199.2000 · Cited by 235
GES-2, a Class A β-Lactamase from Pseudomonas aeruginosa with Increased Hydrolysis of Imipenem
Poirel, L., Weldhagen, G. F., Naas, T., De Champs, C., Dove, M. G., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2598-2603.2001 · Cited by 228
Self-citationRasmussen, B. A., Bush, K., Keeney, D., Yang, Y., Hare, R., O'Gara, C., & Medeiros, A. A. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.9.2080 · Cited by 217
Plasmid-Mediated KPC-2 in a Klebsiella pneumoniae Isolate from China
Wei, Z.-Q., Du, X.-X., Yu, Y.-S., Shen, P., Chen, Y.-G., & Li, L.-J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01053-06 · Cited by 205
Lolans, K., Rice, T. W., Munoz-Price, L. S., & Quinn, J. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00116-06 · Cited by 202
Naas, T., Nordmann, P., Vedel, G., & Poyart, C. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.10.4423-4424.2005 · Cited by 190
Self-citationCarbapenem-Resistant Strain of Klebsiellaoxytoca Harboring Carbapenem-Hydrolyzingβ-LactamaseKPC-2
Yigit, H., Queenan, A. M., Rasheed, J. K., Biddle, J. W., Domenech-Sanchez, A., Alberti, S., Bush, K., & Tenover, F. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3881-3889.2003 · Cited by 187
Naas, T., Vandel, L., Sougakoff, W., Livermore, D. M., & Nordmann, P. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.6.1262 · Cited by 184
Self-citationToleman, M. A., Rolston, K. V., Jones, R. N., & Walsh, T. R. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.329-332.2004 · Cited by 167
Yang, Y. J., Wu, P. J., & Livermore, D. M. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.5.755 · Cited by 163
Carbapenemase-producingEnterobacteriaceae, U.S. Rivers
Aubron, C., Poirel, L., Ash, R. J., & Nordmann, P. (2005) · Emerging infectious diseases · doi:10.3201/eid1102.030684 · Cited by 162
Self-citationNordmann, P., Mariotte, S., Naas, T., Labia, R., & Nicolas, M. H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.939 · Cited by 161
Self-citationNaas, T., & Nordmann, P. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7693 · Cited by 159
Self-citationMetallo-β-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues
Cornaglia, G., Akova, M., Amicosante, G., Cantón, R., Cauda, R., Docquier, J., Edelstein, M. V., Frère, J., Füzi, M., Galleni, M., et al. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2006.10.008 · Cited by 151
Self-citationTurton, J. F., Kaufmann, M. E., Glover, J., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.7.3074-3082.2005 · Cited by 146
Bellais, S., Aubert, D., Naas, T., & Nordmann, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1878-1886.2000 · Cited by 142
Self-citationHéritier, C., Poirel, L., Aubert, D., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.1.268-273.2003 · Cited by 129
Self-citationQueenan, A. M., Torres‐Viera, C., Gold, H. S., Carmeli, Y., Eliopoulos, G. M., Moellering, R. C., Quinn, J. P., Hindler, J. F., Medeiros, A. A., & Bush, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3035-3039.2000 · Cited by 128
Acquired Carbapenem-Hydrolyzing Beta-Lactamases and their Genetic Support
Poirel, L., & Nordmann, P. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378427 · Cited by 110
Self-citationVourli, S., Giakkoupi, P., Miriagou, V., Tzelepi, Ε., Vatopoulos, A. C., & TZOUVELEKIS, L. S. (2004) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2004.tb09535.x · Cited by 107
Coelho, J., Woodford, N., Afzal-Shah, M., & Livermore, D. M. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.756-758.2006 · Cited by 104
Poirel, L. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.561 · Cited by 102
Self-citationPoirel, L., Magalhães, M., Lopes, M., & Nordmann, P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1406-1409.2004 · Cited by 99
Self-citationSader, H. S., Reis, A. O., Silbert, S., & Gales, A. C. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01031.x · Cited by 98
Toleman, M. A., Biedenbach, D. J., Bennett, D. M., Jones, R. N., & Walsh, T. R. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh512 · Cited by 97
Pitout, J. D. D., Chow, B. L., Gregson, D. B., Laupland, K. B., Elsayed, S., & Church, D. L. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.01694-06 · Cited by 95
Self-citationA Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum -lactamase
Wang, C., Cai, P., Chang, D., & Mi, Z. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl116 · Cited by 78
Poirel, L., Héritier, C., Podglajen, I., Sougakoff, W., Gutmann, L., & Nordmann, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.755-758.2003 · Cited by 77
Self-citationHenriques, I. S., Moura, A., Alves, A., Saavedra, M. J., & Correia, A. C. M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2321-2324.2004 · Cited by 76
Zhang, R., Zhou, H. W., Cai, J., & Chen, G. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl541 · Cited by 67
Aubron, C., Poirel, L., Fortineau, N., et al. (2005) · Microbial Drug Resistance · doi:10.1089/mdr.2005.11.254 · Cited by 46
Self-citationNaas, T., Livermore, D. M., & Nordmann, P. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.629 · Cited by 39
Self-citationLee, S. H., Jeong, S. H., & Park, Y. M. (2003) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2003.02040.x · Cited by 39
Bellais, S., Mimoz, O., Léotard, S., Jacolot, A., Petitjean, O., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.2032-2034.2002 · Cited by 35
Self-citation
Cited by
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Yong, D., Toleman, M. A., Giske, C. G., Cho, H. S., Sundman, K., Lee, K., & Walsh, T. R. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00774-09 · Cited by 2,519
Multiplex PCR for detection of acquired carbapenemase genes
Poirel, L., Walsh, T. R., Cuvillier, V., & Nordmann, P. (2011) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2010.12.002 · Cited by 1,991
Self-citationThe real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Nordmann, P., Cuzon, G., & Naas, T. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70054-4 · Cited by 1,579
Self-citationCarbapenems: Past, Present, and Future
Papp-Wallace, K. M., Endimiani, A., Taracila, M. A., & Bonomo, R. A. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-11 · Cited by 1,502
Metadata
- Authors
- Poirel, L., Pitout, J. D., & Nordmann, P.
- Venue
- Future Microbiology
- Publisher
- Informa UK Limited
- Published
- 2007-10
- Volume
- 2
- Issue
- 5
- Pages
- 501-512
- ISSN
- 1746-0913 (ISSN-L)
- 1746-0921
- OpenAlex
- W2124556093
- Cited by
- 309
- References
- 58
- FWCI
- 10.86
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.